FFM
Fairmount Funds Management Portfolio holdings
AUM
$772M
This Quarter Return
+56.06%
1 Year Return
+35.05%
3 Year Return
+1,168.51%
5 Year Return
+1,432.11%
10 Year Return
–
AUM
$630M
AUM Growth
+$630M
(+16%)
Cap. Flow
-$59.9M
Cap. Flow
% of AUM
-9.5%
Top 10 Holdings %
Top 10 Hldgs %
88.37%
Holding
27
New
1
Increased
5
Reduced
1
Closed
11
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$33.7M |
| 2 |
Nuvalent
NUVL
|
$21.1M |
| 3 |
Astria Therapeutics
ATXS
|
$14.7M |
| 4 |
Axsome Therapeutics
AXSM
|
$8.87M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$5.14M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$31M |
| 2 |
Insmed
INSM
|
$28.8M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$24.3M |
| 4 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$21.9M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$12.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALLK
26
DELISTED
Allakos
ALLK
| – | – |
-147,189
| Closed | -$901K |
|
|
27
Acadia Pharmaceuticals
ACAD
$4.34B
| – | – |
-751,804
| Closed | -$12.3M |
|